Advertisement

Home Blood Pressure Monitoring: Primary Role in Hypertension Management

  • George S. StergiouEmail author
  • Anastasios Kollias
  • Marilena Zeniodi
  • Nikos Karpettas
  • Angeliki Ntineri
Blood Pressure Monitoring and Management (G Ogedegbe and JA Staessen, Section Editors)
Part of the following topical collections:
  1. Topical Collection on Blood Pressure Monitoring and Management

Abstract

In the last two decades, considerable evidence on home blood pressure monitoring has accumulated and current guidelines recommend its wide application in clinical practice. First, several outcome studies have shown that the ability of home blood pressure measurements in predicting preclinical target organ damage and cardiovascular events is superior to that of the conventional office blood pressure measurements and similar to that of 24-hour ambulatory monitoring. Second, cross-sectional studies showed considerable agreement of home blood pressure measurements with ambulatory monitoring in detecting the white-coat and masked hypertension phenomena, in both untreated and treated subjects. Third, studies have shown larger blood pressure decline by using home blood pressure monitoring instead of office measurements for treatment adjustment. Fourth, in treated hypertensives, home blood pressure monitoring has been shown to improve long-term adherence to antihypertensive drug treatment and thus, has improved hypertension control rates. These data suggest that home blood pressure should no longer be regarded as only a screening tool that requires confirmation by ambulatory monitoring. Provided that an unbiased assessment is obtained according to current recommendations, home blood pressure monitoring should have primary role in diagnosis, treatment adjustment, and long-term follow-up of most cases with hypertension.

Keywords

Adjustment Ambulatory blood pressure Decision-making Diagnosis Self-measurement Treatment 

Notes

Compliance with Ethics Guidelines

Conflict of Interest Anastasios Kollias, Marilena Zeniodi, Nikos Karpettas, and Angeliki Ntineri declare that they have no conflicts of interest.

George S. Stergiou has received honoraria for educational lectures from Omron and consultation fees from Microlife.

Human and Animal Rights and Informed Consent This article does not contain any studies with human or animal subjects performed by any of the authors.

References

Papers of particular interest, published recently, have been highlighted as: • Of importance

  1. 1.
    Mancia G, Fagard R, Narkiewicz K, Redón J, Zanchetti A, Böhm M, et al. 2013 ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;31:1281–357.PubMedGoogle Scholar
  2. 2.
    Parati G, Stergiou GS, Asmar R, Bilo G, de Leeuw P, Imai Y, et al. European Society of Hypertension guidelines for blood pressure monitoring at home: a summary report of the Second International Consensus Conference on Home Blood Pressure Monitoring. J Hypertens. 2008;26:1505–26.PubMedGoogle Scholar
  3. 3.•
    O’Brien E, Parati G, Stergiou G, Asmar R, Beilin L, Bilo G, et al. European Society of Hypertension position paper on ambulatory blood pressure monitoring. J Hypertens. 2013;31:1731–68. Recent European guidelines on ambulatory blood pressure monitoring with complete review of the evidence.PubMedGoogle Scholar
  4. 4.•
    Stergiou GS, Asayama K, Thijs L, Kollias A, Niiranen TJ, Hozawa A, et al. International Database on HOme blood pressure in relation to Cardiovascular Outcome (IDHOCO) Investigators. Prognosis of white-coat and masked hypertension: international database of home blood pressure in relation to cardiovascular outcome. Hypertension. 2014;63:675–82. Individual data analysis of five populations (n = 6458, follow-up 8.3 years) showing increased cardiovascular risk in untreated and treated masked hypertensives detected by home measurements, whereas the white-coat hypertension phenomenon was a risk factor only in untreated subjects.PubMedGoogle Scholar
  5. 5.
    Bliziotis IA, Destounis A, Stergiou GS. Home versus ambulatory and office blood pressure in predicting target organ damage in hypertension: a systematic review and meta-analysis. J Hypertens. 2012;30:1289–99.PubMedGoogle Scholar
  6. 6.
    Stergiou GS, Bliziotis IA. Home blood pressure monitoring in the diagnosis and treatment of hypertension: a systematic review. Am J Hypertens. 2011;24:123–34.PubMedGoogle Scholar
  7. 7.
    Stergiou GS, Siontis KC, Ioannidis JP. Home blood pressure as a cardiovascular outcome predictor: it’s time to take this method seriously. Hypertension. 2010;55:1301–3.PubMedGoogle Scholar
  8. 8.
    Ward AM, Takahashi O, Stevens R, Heneghan C. Home measurement of blood pressure and cardiovascular disease: systematic review and meta-analysis of prospective studies. J Hypertens. 2012;30:449–56.PubMedGoogle Scholar
  9. 9.
    Karpettas N, Destounis A, Kollias A, Nasothimiou E, Moyssakis I, Stergiou GS. Prediction of treatment-induced changes in target-organ damage using changes in clinic, home and ambulatory blood pressure. Hypertens Res. 2014.Google Scholar
  10. 10.
    Mancia G, Facchetti R, Bombelli M, Grassi G, Sega R. Long-term risk of mortality associated with selective and combined elevation in office, home, and ambulatory blood pressure. Hypertension. 2006;47:846–53.PubMedGoogle Scholar
  11. 11.
    Hansen TW, Kikuya M, Thijs L, Björklund-Bodegård K, Kuznetsova T, Ohkubo T, et al. IDACO Investigators. Prognostic superiority of daytime ambulatory over conventional blood pressure in four populations: a meta-analysis of 7,030 individuals. J Hypertens. 2007;25:1554–64.PubMedGoogle Scholar
  12. 12.
    Nesbitt SD, Amerena JV, Grant E, Jamerson KA, Lu H, Weder A, et al. Home blood pressure as a predictor of future blood pressure stability in borderline hypertension. The Tecumseh Study. Am J Hypertens. 1997;10:1270–80.PubMedGoogle Scholar
  13. 13.
    Stergiou GS, Zourbaki AS, Skeva II, Mountokalakis TD. White coat effect detected using self-monitoring of blood pressure at home: comparison with ambulatory blood pressure. Am J Hypertens. 1998;11:820–7.PubMedGoogle Scholar
  14. 14.
    Stergiou GS, Skeva II, Baibas NM, Kalkana CB, Roussias LG, Mountokalakis TD. Diagnosis of hypertension using home or ambulatory blood pressure monitoring: comparison with the conventional strategy based on repeated clinic blood pressure measurements. J Hypertens. 2000;18:1745–51.PubMedGoogle Scholar
  15. 15.
    Masding MG, Jones JR, Bartley E, Sandeman DD. Assessment of blood pressure in patients with type 2 diabetes: comparison between home blood pressure monitoring, clinic blood pressure measurement and 24-h ambulatory blood pressure monitoring. Diabet Med. 2001;18:431–7.PubMedGoogle Scholar
  16. 16.
    Hond ED, Celis H, Fagard R, Keary L, Leeman M, O’Brien E, et al. THOP investigators. Self-measured versus ambulatory blood pressure in the diagnosis of hypertension. J Hypertens. 2003;21:717–22.PubMedGoogle Scholar
  17. 17.
    Stergiou GS, Efstathiou SP, Argyraki CK, Roussias LG, Mountokalakis TD. White coat effect in treated versus untreated hypertensive individuals: a case-control study using ambulatory and home blood pressure monitoring. Am J Hypertens. 2004;17:124–8.PubMedGoogle Scholar
  18. 18.
    Bayó J, Cos FX, Roca C, Dalfó A, Martín-Baranera MM, Albert B. Home blood pressure self-monitoring: diagnostic performance in white-coat hypertension. Blood Press Monit. 2006;11:47–52.PubMedGoogle Scholar
  19. 19.
    Shimbo D, Kuruvilla S, Haas D, Pickering TG, Schwartz JE, Gerin W. Preventing misdiagnosis of ambulatory hypertension: algorithm using office and home blood pressures. J Hypertens. 2009;27:1775–83.PubMedPubMedCentralGoogle Scholar
  20. 20.
    McGowan N, Padfield PL. Self blood pressure monitoring: a worthy substitute for ambulatory blood pressure? J Hum Hypertens. 2010;24:801–6.PubMedGoogle Scholar
  21. 21.•
    Nasothimiou EG, Tzamouranis D, Rarra V, Roussias LG, Stergiou GS. Diagnostic accuracy of home vs. ambulatory blood pressure monitoring in untreated and treated hypertension. Hypertens Res. 2012;35:750–5. The largest cross-sectional study (n = 613) on the diagnostic accuracy of home compared to ambulatory blood pressure with separate analyses in untreated and treated subjects.PubMedGoogle Scholar
  22. 22.
    Almeida AE, Stein R, Gus M, Nascimento JA, Arévalo JR, Fuchs FD, et al. Improved diagnostic accuracy of a 3-day protocol of home blood pressure monitoring for the diagnosis of arterial hypertension. Blood Press Monit. 2013;18:119–26.PubMedGoogle Scholar
  23. 23.
    Stergiou GS, Baibas NM, Gantzarou AP, Skeva II, Kalkana CB, Roussias LG, et al. Reproducibility of home, ambulatory, and clinic blood pressure: implications for the design of trials for the assessment of antihypertensive drug efficacy. Am J Hypertens. 2002;15:101–4.PubMedGoogle Scholar
  24. 24.
    Stergiou GS, Salgami EV, Tzamouranis DG, Roussias LG. Masked hypertension assessed by ambulatory blood pressure versus home blood pressure monitoring: is it the same phenomenon? Am J Hypertens. 2005;18:772–8.PubMedGoogle Scholar
  25. 25.
    Stergiou GS, Nasothimiou EG, Destounis A, Poulidakis E, Evagelou I, Tzamouranis D. Assessment of the diurnal blood pressure profile and detection of non-dippers based on home or ambulatory monitoring. Am J Hypertens. 2012;25:974–8.PubMedGoogle Scholar
  26. 26.
    Nasothimiou EG, Tzamouranis D, Roussias LG, Stergiou GS. Home versus ambulatory blood pressure monitoring in the diagnosis of clinic resistant and true resistant hypertension. J Hum Hypertens. 2012;26:696–700.PubMedGoogle Scholar
  27. 27.
    Comas A, González-Nuevo JP, Plaza F, Barreda MJ, Madiedo R, Pajón P, et al. Home self-monitoring of arterial pressure: identification of the white coat reaction. Aten Primaria. 1999;24:5–11.PubMedGoogle Scholar
  28. 28.
    Llisterri JL, Gil VF, Rodríguez G, Orozco D, García A, Merino J. Interest of home blood pressure measurements to establish degree of hypertensive control. Blood Press. 2003;12:220–4.PubMedGoogle Scholar
  29. 29.
    Martínez MA, Sancho T, García P, Moreno P, Rubio JM, Palau FJ, et al. Home blood pressure in poorly controlled hypertension: relationship with ambulatory blood pressure and organ damage. Blood Press Monit. 2006;11:207–13.PubMedGoogle Scholar
  30. 30.
    Mancia G, Zanchetti A, Agabiti-Rosei E, Benemio G, De Cesaris R, Fogari R, et al. Ambulatory blood pressure is superior to clinic blood pressure in predicting treatment-induced regression of left ventricular hypertrophy. SAMPLE Study Group. Study on Ambulatory Monitoring of Blood Pressure and Lisinopril Evaluation. Circulation. 1997;95:1464–70.PubMedGoogle Scholar
  31. 31.
    Zarnke KB, Feagan BG, Mahon JL, Feldman RD. A randomized study comparing a patient-directed hypertension management strategy with usual office-based care. Am J Hypertens. 1997;10:58–67.PubMedGoogle Scholar
  32. 32.
    Broege PA, James GD, Pickering TG. Management of hypertension in the elderly using home blood pressures. Blood Press Monit. 2001;6:139–44.PubMedGoogle Scholar
  33. 33.
    Staessen JA, Den Hond E, Celis H, Fagard R, Keary L, Vandenhoven G, et al. Treatment of Hypertension Based on Home or Office Blood Pressure (THOP) Trial Investigators. Antihypertensive treatment based on blood pressure measurement at home or in the physician’s office: a randomized controlled trial. JAMA. 2004;291:955–64.PubMedGoogle Scholar
  34. 34.
    Halme L, Vesalainen R, Kaaja M, Kantola I. HOme MEasuRement of blood pressure study group. Self-monitoring of blood pressure promotes achievement of blood pressure target in primary health care. Am J Hypertens. 2005;18:1415–20.PubMedGoogle Scholar
  35. 35.
    Verberk WJ, Kroon AA, Lenders JW, Kessels AG, van Montfrans GA, Smit AJ, et al. Home versus office measurement, reduction of unnecessary treatment study investigators. Self-measurement of blood pressure at home reduces the need for antihypertensive drugs: a randomized, controlled trial. Hypertension. 2007;50:1019–25.PubMedGoogle Scholar
  36. 36.
    Tobe SW, Hunter K, Geerts R, Raymond N, Pylypchuk G. Canadian Hypertension Society. IMPPACT: Investigation of Medical Professionals and Patients Achieving Control Together. Can J Cardiol. 2008;24:205–8.PubMedPubMedCentralGoogle Scholar
  37. 37.
    McManus RJ, Mant J, Bray EP, Holder R, Jones MI, Greenfield S, et al. Telemonitoring and self‑management in the control of hypertension (TASMINH2): a randomized controlled trial. Lancet. 2010;376:163–72.PubMedGoogle Scholar
  38. 38.
    Niiranen TJ, Kantola IM, Vesalainen R, Johansson J, Ruuska MJ. A comparison of home measurement and ambulatory monitoring of blood pressure in the adjustment of antihypertensive treatment. Am J Hypertens. 2006;19:468–74.PubMedGoogle Scholar
  39. 39.•
    Stergiou GS, Karpettas N, Destounis A, Tzamouranis D, Nasothimiou E, Kollias A, et al. Home blood pressure monitoring alone vs. combined clinic and ambulatory measurements in following treatment-induced changes in blood pressure and organ damage. Am J Hypertens. 2014;27:184–92. Randomized trial showing no difference in blood pressure decline, hypertension control, and preclinical organ damage regression by using home blood pressure alone or combined office and ambulatory blood pressure for treatment initiation and titration for 1 year.PubMedGoogle Scholar
  40. 40.
    Ogedegbe G, Schoenthaler A. A systematic review of the effects of home blood pressure monitoring on medication adherence. J Clin Hypertens (Greenwich). 2006;8:174–80.Google Scholar
  41. 41.•
    Agarwal R, Bills JE, Hecht TJ, Light RP. Role of home blood pressure monitoring in overcoming therapeutic inertia and improving hypertension control: a systematic review and meta-analysis. Hypertension. 2011;57:29–38. Systematic review and meta-analysis of 37 randomized trials showing that home blood pressure monitoring is associated with more frequent antihypertensive medication reductions, less therapeutic inertia and improved hypertension control and can be further enhanced by telemonitoring.PubMedGoogle Scholar
  42. 42.
    Glynn LG, Murphy AW, Smith SM, Schroeder K, Fahey T. Self-monitoring and other non-pharmacological interventions to improve the management of hypertension in primary care: a systematic review. Br J Gen Pract. 2010;60:e476–88.PubMedPubMedCentralGoogle Scholar
  43. 43.
    Fuchs SC, Ferreira-da-Silva AL, Moreira LB, Neyeloff JL, Fuchs FC, Gus M, et al. Efficacy of isolated home blood pressure monitoring for blood pressure control: randomized controlled trial with ambulatory blood pressure monitoring - MONITOR study. J Hypertens. 2012;30:75–80.PubMedGoogle Scholar
  44. 44.
    Cuspidi C, Meani S, Fusi V, Salerno M, Valerio C, Severgnini B, et al. Home blood pressure measurement and its relationship with blood pressure control in a large selected hypertensive population. J Hum Hypertens. 2004;18:725–31.PubMedGoogle Scholar
  45. 45.
    Bloch MJ, Basile JN. UK guidelines call for routine 24-hour ambulatory blood pressure monitoring in all patients to make the diagnosis of hypertension - not ready for prime time in the United States. J Clin Hypertens. 2011;13:871–2.Google Scholar
  46. 46.
    James K, Dolan E, O’Brien E. Making ambulatory blood pressure monitoring accessible in pharmacies. Blood Press Monit. 2014;19:134–9.PubMedGoogle Scholar
  47. 47.
    Little P, Barnett J, Barnsley L, Marjoram J, Fitzgerald-Barron A, Mant D. Comparison of acceptability of and preferences for different methods of measuring blood pressure in primary care. Br Med J. 2002;325:358–9.Google Scholar
  48. 48.
    Nasothimiou EG, Karpettas N, Dafni MG, Stergiou GS. Patients’ preference for ambulatory versus home blood pressure monitoring. J Hum Hypertens. 2014;28:224–9.PubMedGoogle Scholar
  49. 49.•
    Myers MG, Stergiou GS. Reporting bias: Achilles’ heel of home blood pressure monitoring. J Am Soc Hypertens. 2014;8:350–7. A review of the evidence on the main drawback of home blood pressure monitoring, its impact on decision-making, and measures for its prevention. PubMedGoogle Scholar
  50. 50.
    Pickering TG, Miller NH, Ogedegbe G, Krakoff LR, Artinian NT, Goff D, et al. Call to action on use and reimbursement for home blood pressure monitoring: executive summary: a joint scientific statement from the American Heart Association, American Society of Hypertension, and Preventive Cardiovascular Nurses Association. Hypertension. 2008;52:1–9.PubMedGoogle Scholar
  51. 51.
    Stergiou GS, Jaenecke B, Giovas PP, Chang A, Chung-Yueh Y, Tan TM. A tool for reliable self-home blood pressure monitoring designed according to the European Society of Hypertension recommendations: the Microlife WatchBP Home monitor. Blood Press Monit. 2007;12:127–31.PubMedGoogle Scholar
  52. 52.
    AbuDagga A, Resnick HE, Alwan M. Impact of blood pressure telemonitoring on hypertension outcomes: a literature review. Telemed J E Health. 2010;16:830–8.PubMedGoogle Scholar
  53. 53.
    Zullig LL, Melnyk SD, Goldstein K, Shaw RJ, Bosworth HB. The role of home blood pressure telemonitoring in managing hypertensive populations. Curr Hypertens Rep. 2013;15:346–55.PubMedPubMedCentralGoogle Scholar
  54. 54.•
    Omboni S, Gazzola T, Carabelli G, Parati G. Clinical usefulness and cost effectiveness of home blood pressure telemonitoring: meta-analysis of randomized controlled studies. J Hypertens. 2013;31:455–67. Systematic review and meta-analysis of 23 randomized trials (n = 7037 patients) showing that home blood pressure telemonitoring may improve hypertension control and associated healthcare outcomes.PubMedGoogle Scholar
  55. 55.
    Stergiou GS, Nasothimiou EG. Hypertension: Does home telemonitoring improve hypertension management? Nat Rev Nephrol. 2011;7:493–5.PubMedGoogle Scholar
  56. 56.
    National Institute for Health and Clinical Excellence (NICE). Hypertension. The clinical management of primary hypertension in adults. Clinical Guideline 127. 2011. www.nice.org.uk/guidance/CG127. Accessed 12 Apr 2014.

Copyright information

© Springer Science+Business Media New York 2014

Authors and Affiliations

  • George S. Stergiou
    • 1
    Email author
  • Anastasios Kollias
    • 1
  • Marilena Zeniodi
    • 1
  • Nikos Karpettas
    • 1
  • Angeliki Ntineri
    • 1
  1. 1.Hypertension Center, STRIDE Hellas-7, Third University Department of MedicineSotiria HospitalAthensGreece

Personalised recommendations